The Kі-67 marker for assessing the effectiveness of systemic or regional neoadjuvant polychemotherapy in patients with locally advanced breast cancer
Summary. Over the past decades, breast cancer (BC) is the most common cancer and one of the key causes of mortality and disability among women in developed countries. Aim: Determination of the role of Ki-67 index in assessing the quality of neoadjuvant polychemotherapy treatment using regio...
Збережено в:
| Дата: | 2023 |
|---|---|
| Автори: | , , |
| Формат: | Стаття |
| Мова: | English |
| Опубліковано: |
PH Akademperiodyka
2023
|
| Теми: | |
| Онлайн доступ: | https://exp-oncology.com.ua/index.php/Exp/article/view/2019-2-14 |
| Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
| Назва журналу: | Experimental Oncology |
Репозитарії
Experimental Oncology| id |
oai:ojs2.ex.aqua-time.com.ua:article-255 |
|---|---|
| record_format |
ojs |
| spelling |
oai:ojs2.ex.aqua-time.com.ua:article-2552023-10-11T16:41:24Z The Kі-67 marker for assessing the effectiveness of systemic or regional neoadjuvant polychemotherapy in patients with locally advanced breast cancer The Kі-67 marker for assessing the effectiveness of systemic or regional neoadjuvant polychemotherapy in patients with locally advanced breast cancer Dumanskiy, Y.V. Bondar, O.V. Stoliarchuk, E.A. immunohistochemistry, locally advanced breast cancer, neoadjuvant polychemotherapy, Кі-67 immunohistochemistry, locally advanced breast cancer, neoadjuvant polychemotherapy, Кі-67 Summary. Over the past decades, breast cancer (BC) is the most common cancer and one of the key causes of mortality and disability among women in developed countries. Aim: Determination of the role of Ki-67 index in assessing the quality of neoadjuvant polychemotherapy treatment using regional or systemic delivery routes of pharmacological agents in patients with locally advanced breast cancer (LABC). Materials and Methods: The retrospective analysis of 30 clinical trials of LABC treatment based on selective intra-arterial therapy in patients with BC (T4A-DN0-3M0) was used. Results: The decrease in Ki-67 level in LABC after selective intra-arterial polychemotherapy was more pronounced than after systemic polychemotherapy. No correlation of the tumor metastatic potential with a Ki-67 level was detected. Conclusion: Assessment of Ki-67 expression allows to evaluate effectively the biological properties of the tumor, predict the course of the disease and choose the optimal tactics of neoadjuvant polychemotherapy (regional or systemic variant) as part of integrated antitumor treatment. Summary. Over the past decades, breast cancer (BC) is the most common cancer and one of the key causes of mortality and disability among women in developed countries. Aim: Determination of the role of Ki-67 index in assessing the quality of neoadjuvant polychemotherapy treatment using regional or systemic delivery routes of pharmacological agents in patients with locally advanced breast cancer (LABC). Materials and Methods: The retrospective analysis of 30 clinical trials of LABC treatment based on selective intra-arterial therapy in patients with BC (T4A-DN0-3M0) was used. Results: The decrease in Ki-67 level in LABC after selective intra-arterial polychemotherapy was more pronounced than after systemic polychemotherapy. No correlation of the tumor metastatic potential with a Ki-67 level was detected. Conclusion: Assessment of Ki-67 expression allows to evaluate effectively the biological properties of the tumor, predict the course of the disease and choose the optimal tactics of neoadjuvant polychemotherapy (regional or systemic variant) as part of integrated antitumor treatment. PH Akademperiodyka 2023-06-05 Article Article application/pdf https://exp-oncology.com.ua/index.php/Exp/article/view/2019-2-14 10.32471/exp-oncology.2312-8852.vol-41-no-2.13303 Experimental Oncology; Vol. 41 No. 2 (2019): Experimental Oncology; 176-178 Експериментальна онкологія; Том 41 № 2 (2019): Експериментальна онкологія; 176-178 2312-8852 1812-9269 10.32471/exp-oncology.2312-8852.vol-41-no-2 en https://exp-oncology.com.ua/index.php/Exp/article/view/2019-2-14/2019-2-14 Copyright (c) 2023 Experimental Oncology https://creativecommons.org/licenses/by-nc/4.0/ |
| institution |
Experimental Oncology |
| baseUrl_str |
|
| datestamp_date |
2023-10-11T16:41:24Z |
| collection |
OJS |
| language |
English |
| topic |
immunohistochemistry locally advanced breast cancer neoadjuvant polychemotherapy Кі-67 |
| spellingShingle |
immunohistochemistry locally advanced breast cancer neoadjuvant polychemotherapy Кі-67 Dumanskiy, Y.V. Bondar, O.V. Stoliarchuk, E.A. The Kі-67 marker for assessing the effectiveness of systemic or regional neoadjuvant polychemotherapy in patients with locally advanced breast cancer |
| topic_facet |
immunohistochemistry locally advanced breast cancer neoadjuvant polychemotherapy Кі-67 immunohistochemistry locally advanced breast cancer neoadjuvant polychemotherapy Кі-67 |
| format |
Article |
| author |
Dumanskiy, Y.V. Bondar, O.V. Stoliarchuk, E.A. |
| author_facet |
Dumanskiy, Y.V. Bondar, O.V. Stoliarchuk, E.A. |
| author_sort |
Dumanskiy, Y.V. |
| title |
The Kі-67 marker for assessing the effectiveness of systemic or regional neoadjuvant polychemotherapy in patients with locally advanced breast cancer |
| title_short |
The Kі-67 marker for assessing the effectiveness of systemic or regional neoadjuvant polychemotherapy in patients with locally advanced breast cancer |
| title_full |
The Kі-67 marker for assessing the effectiveness of systemic or regional neoadjuvant polychemotherapy in patients with locally advanced breast cancer |
| title_fullStr |
The Kі-67 marker for assessing the effectiveness of systemic or regional neoadjuvant polychemotherapy in patients with locally advanced breast cancer |
| title_full_unstemmed |
The Kі-67 marker for assessing the effectiveness of systemic or regional neoadjuvant polychemotherapy in patients with locally advanced breast cancer |
| title_sort |
kі-67 marker for assessing the effectiveness of systemic or regional neoadjuvant polychemotherapy in patients with locally advanced breast cancer |
| title_alt |
The Kі-67 marker for assessing the effectiveness of systemic or regional neoadjuvant polychemotherapy in patients with locally advanced breast cancer |
| description |
Summary. Over the past decades, breast cancer (BC) is the most common cancer and one of the key causes of mortality and disability among women in developed countries. Aim: Determination of the role of Ki-67 index in assessing the quality of neoadjuvant polychemotherapy treatment using regional or systemic delivery routes of pharmacological agents in patients with locally advanced breast cancer (LABC). Materials and Methods: The retrospective analysis of 30 clinical trials of LABC treatment based on selective intra-arterial therapy in patients with BC (T4A-DN0-3M0) was used. Results: The decrease in Ki-67 level in LABC after selective intra-arterial polychemotherapy was more pronounced than after systemic polychemotherapy. No correlation of the tumor metastatic potential with a Ki-67 level was detected. Conclusion: Assessment of Ki-67 expression allows to evaluate effectively the biological properties of the tumor, predict the course of the disease and choose the optimal tactics of neoadjuvant polychemotherapy (regional or systemic variant) as part of integrated antitumor treatment. |
| publisher |
PH Akademperiodyka |
| publishDate |
2023 |
| url |
https://exp-oncology.com.ua/index.php/Exp/article/view/2019-2-14 |
| work_keys_str_mv |
AT dumanskiyyv thekí67markerforassessingtheeffectivenessofsystemicorregionalneoadjuvantpolychemotherapyinpatientswithlocallyadvancedbreastcancer AT bondarov thekí67markerforassessingtheeffectivenessofsystemicorregionalneoadjuvantpolychemotherapyinpatientswithlocallyadvancedbreastcancer AT stoliarchukea thekí67markerforassessingtheeffectivenessofsystemicorregionalneoadjuvantpolychemotherapyinpatientswithlocallyadvancedbreastcancer AT dumanskiyyv kí67markerforassessingtheeffectivenessofsystemicorregionalneoadjuvantpolychemotherapyinpatientswithlocallyadvancedbreastcancer AT bondarov kí67markerforassessingtheeffectivenessofsystemicorregionalneoadjuvantpolychemotherapyinpatientswithlocallyadvancedbreastcancer AT stoliarchukea kí67markerforassessingtheeffectivenessofsystemicorregionalneoadjuvantpolychemotherapyinpatientswithlocallyadvancedbreastcancer |
| first_indexed |
2025-07-17T12:17:07Z |
| last_indexed |
2025-07-17T12:17:07Z |
| _version_ |
1837896436502495232 |